The Company identified opportunities for improvements in its workforce realignment, strategy and staffing, and increased its focus on performance management, to ensure it has the right skillsets and number of associates to execute its long-term vision. As such, the Company extended voluntary and involuntary severance and separation benefits to certain associates in order to facilitate its workforce realignment. In addition, the Company engaged consultants to assist in reviewing the optimization of the Company’s operations and improving profitability with executing on its Company-wide initiative, referred to as Mission Critical, through fiscal year 2023.

The following table summarizes restructuring and other costs for the thirteen weeks ended December 3, 2022 and November 27, 2021:


	Thirteen Weeks Ended
	December 3,		November 27,
	2022		2021
Consulting-related costs	$	1,575	$	—
Associate severance and separation costs		519		3,515
Equity award acceleration costs associated with severance		—		1,729
Other exit-related costs		—		39
Total restructuring and other costs	$	2,094	$	5,283

Liabilities associated with restructuring and other costs are included in Accrued expenses and other current liabilities in the unaudited Condensed Consolidated Balance Sheet as of December 3, 2022. The following table summarizes activity related to liabilities associated with restructuring and other costs for the thirteen weeks ended December 3, 2022:


	Consulting-related costs		Associate severance and separation costs		Total
Balance as of September 3, 2022	$	840	$	1,874	$	2,714
Additions		1,575		519		2,094
Payments and other adjustments		(1,315)		(1,504)		(2,819)
Balance as of December 3, 2022	$	1,100	$	889	$	1,989